metformin and dolutegravir

metformin has been researched along with dolutegravir in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	5 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Borland, J; Bowers, GD; Choukour, M; Humphreys, JE; Jerva, F; Song, IH; Wynne, B; Zamek-Gliszczynski, MJ; Zong, J	1
Cattaneo, D; Clementi, E; Gervasoni, C; Minisci, D; Rizzardini, G	1
Badowski, ME; Fulco, PP; Liedtke, MD; Masich, A	1
Fong, IW; Naccarato, M; Yoong, D	1
Cattaneo, D; Gervasoni, C; Resnati, C; Rizzardini, G	1

Trials

1 trial(s) available for metformin and dolutegravir

Article	Year
The Effect of Dolutegravir on the Pharmacokinetics of Metformin in Healthy Subjects. Journal of acquired immune deficiency syndromes (1999), 2016, 08-01, Volume: 72, Issue:4 Topics: Adult; Area Under Curve; Blood Glucose; Cross-Over Studies; Drug Administration Schedule; Drug Interactions; Female; Healthy Volunteers; Heterocyclic Compounds, 3-Ring; HIV Integrase Inhibitors; Humans; Hypoglycemic Agents; Male; Metformin; Oxazines; Patient Safety; Piperazines; Pyridones; Treatment Outcome	2016

Article

Year

The Effect of Dolutegravir on the Pharmacokinetics of Metformin in Healthy Subjects.

Journal of acquired immune deficiency syndromes (1999), 2016, 08-01, Volume: 72, Issue:4

Topics: Adult; Area Under Curve; Blood Glucose; Cross-Over Studies; Drug Administration Schedule; Drug Interactions; Female; Healthy Volunteers; Heterocyclic Compounds, 3-Ring; HIV Integrase Inhibitors; Humans; Hypoglycemic Agents; Male; Metformin; Oxazines; Patient Safety; Piperazines; Pyridones; Treatment Outcome

2016

Other Studies

4 other study(ies) available for metformin and dolutegravir

Article	Year
How Relevant is the Interaction Between Dolutegravir and Metformin in Real Life? Journal of acquired immune deficiency syndromes (1999), 2017, 05-01, Volume: 75, Issue:1 Topics: Area Under Curve; CD4 Lymphocyte Count; Diabetes Mellitus, Type 2; Drug Interactions; Drug Therapy, Combination; Female; Glycated Hemoglobin; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Oxazines; Piperazines; Pyridones; Retrospective Studies; Treatment Outcome	2017
Evaluation of the concurrent use of dolutegravir and metformin in human immunodeficiency virus-infected patients. International journal of STD & AIDS, 2017, Volume: 28, Issue:12 Topics: Adult; Aged; CD4 Lymphocyte Count; Creatinine; Drug-Related Side Effects and Adverse Reactions; Female; Glycated Hemoglobin; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; HIV-1; Humans; Male; Metformin; Middle Aged; Oxazines; Piperazines; Pyridones; RNA, Viral; Treatment Outcome; Viral Load	2017
Dolutegravir and metformin: a case of hyperlactatemia. AIDS (London, England), 2017, Sep-24, Volume: 31, Issue:15 Topics: Aged; Drug Interactions; Drug Therapy, Combination; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Hyperlactatemia; Metformin; Oxazines; Piperazines; Pyridones	2017
Dolutegravir and metformin: a clinically relevant or just a pharmacokinetic interaction? AIDS (London, England), 2018, 02-20, Volume: 32, Issue:4 Topics: Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Hyperlactatemia; Metformin; Oxazines; Piperazines; Pyridones	2018